-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Fighting Alzheimer's with 'decoy receptors'Using an innovative approach, scientists move one step closer to a treatment for Alzheimer’s. Learning how to tame the brain’s immune system is vital. -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
New potential biotherapy for Alzheimer's disease — ScienceDailyResearchers have discovered that a modified version of an important immune cell protein could be used to treat Alzheimer’s disease. The study reveals that soluble versions of a protein called TLR5… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Research reveals a potential new biotherapy for Alzheimer’s diseaseWhen tested in mice, the therapy reduced amyloid plaques, a characteristic feature of Alzheimer’s. No drug available today can prevent or… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
CAD106 and CNP520, potential new drug treatments for AD, are being investigated as potential treatments. This study is recruiting AD patients from across the U.S.
400 Bad Requesthttps://clinicaltrials.gov/ct2/show/study/NCT02565511?term=alzheimer&recrs=a&rank=9&show_locs=Y#locnYour browser sent a request that this server… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
The body is a system. Researchers are using this to our advantage as the development of amyloid plaques is linked to retina thinning which is a symptom we can inexpensively monitor.
Alzheimer's one day may be predicted during eye exam: Noninvasive test may screen for disease before symptoms appear –… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
We currently have 5 million people living with AD today and projected to have 14 million people living with AD by 2050. Research continues to ask the fundamental questions about the characteristics of AD.
Alzheimer's tied to brain's 'waste removal system'A new… -
Georgina joined the group
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Sleep is for the weak? Dr. Bendlin and her team are taking sleep more seriously as their longitudinal study indicates that sleep deprivation is linked to biomarkers of AD.
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Alzheimer's Natural Treatment Options & Notable Breakthroughs – Dr. AxeSee what the latest research finds in our fight to prevent, treat and reverse this horrible disease. -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Sanfilippo syndrome is a rare and fatal form of AD that affects children. The dire need for more research and treatment options is felt by all populations in our communities.
Two-year-old boy with condition dubbed 'childhood Alzheimer’s' thought to be youngest ever diagnosed in UK | The I… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
A study in Virginia is recruiting to evaluate if irradiation is an effective treatment for plaques.
-
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
As the study of genetics continue to advance, often we are left with more questions in deciphering nature’s patterns.
Why some people with brain markers of Alzheimer's have no dementia — ScienceDailyA new study has uncovered why some people that have brain… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
New developments in Parkinson’s and Alzheimer’s research – YouTubeClare Mackay, Professor of Imaging Neuroscience and Masud Husain, Professor of Neurology and Cognitive Neuroscience are senior researchers at the National In… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
Benzodiazepines are associated with increased risk of Alzheimer's disease — ScienceDailyThe use of benzodiazepines and related drugs (Z drugs) is associated with a modestly increased risk of Alzheimer’s disease, according to a recent study. -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Approved Drugs for Alzheimer's Disease – Alzheimer's News TodayRead about the five prescription medicines approved by the FDA to treat Alzheimer’s symptoms that impact thinking and memory, and disease stages they treat. -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Drugs in development for cancer may also fight brain diseases, including ALS: PARP inhibitors show promise in preventing toxic accumulations of brain disease proteins — ScienceDailyA class of cancer drugs called PARP inhibitors could be useful for… -
raineealexis posted an update in the group Alzheimer’s Disease Advocate Network
University College London analyzed trends in AD and dementias to see if there are any trends among different ethnicities but information also indicated that diagnosis differs. This reminds us that diagnoses aren’t an exact standard protocol but the best efforts put by our healthcare teams. We have to work together to continue the push for…[Read more]
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
This US-POINTER trial will test a 2-year multi-site and community-based multi domain intervention of physical activity, nutritional guidance, cognitive training and social activities, and management of medical co-morbidities for Alzheimer’s patients.
U.S. POINTER | Alzheimer's… -
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
new data from the SPRINT MIND trial is an exciting first in our understanding of how aggressively treating systolic blood pressure could be part of a solution to treat Alzheimer’s.
-
CarlsonTeke2 posted an update in the group Alzheimer’s Disease Advocate Network
Previous studies have shown changes to the brain as early as 10 to 20 years before the symptoms of Alzheimer’s Disease arise, but this body-worn sensors may help detect onset of Alzheimer’s disease.
Gait assessed with body-worn sensors may help detect onset of Alzheimer’s disease | Journal of Alzheimer's Dis… - Load More